Intravitreal Aflibercept Injection (IAI) for Persistent Diabetic Macular Edema (DME) after Treatment with Bevacizumab and/or Ranibizumab: 6-Month ROTATED Trial Results

Marcus Dennis M.; Frazier Heather; Rex Priscila; Marcus William; Starnes Davis; Walia Harveen; Singh Harinderjit; Lalane Robert

首页> 外文期刊>Investigative ophthalmology & visual science >Intravitreal Aflibercept Injection (IAI) for Persistent Diabetic Macular Edema (DME) after Treatment with Bevacizumab and/or Ranibizumab: 6-Month ROTATED Trial Results

【24h】

Intravitreal Aflibercept Injection (IAI) for Persistent Diabetic Macular Edema (DME) after Treatment with Bevacizumab and/or Ranibizumab: 6-Month ROTATED Trial Results

机译：用Bevacizumab和/或Ranibizumab治疗后玻术患者玻璃体糖尿病（IAI）用于持续糖尿病黄斑水肿（DME）：6个月的旋转试验结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Investigative ophthalmology & visual science》 |2018年第9期|共3页
作者
Marcus Dennis M.; Frazier Heather; Rex Priscila; Marcus William; Starnes Davis; Walia Harveen; Singh Harinderjit; Lalane Robert;
展开▼
作者单位

Southeast Retina Ctr Augusta GA USA;

Southeast Retina Ctr Augusta GA USA;

Southeast Retina Ctr Augusta GA USA;

Southeast Retina Ctr Augusta GA USA;

Southeast Retina Ctr Augusta GA USA;

Southeast Retina Ctr Augusta GA USA;

Southeast Retina Ctr Augusta GA USA;

Southeast Retina Ctr Augusta GA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Intravitreal Aflibercept Injection (IAI) for Persistent Diabetic Macular Edema (DME) after Treatment with Bevacizumab and/or Ranibizumab: 6-Month ROTATED Trial Results [J] . Marcus Dennis M., Frazier Heather, Rex Priscila, Investigative ophthalmology & visual science . 2018,第9期

机译：用Bevacizumab和/或Ranibizumab治疗后玻术患者玻璃体糖尿病（IAI）用于持续糖尿病黄斑水肿（DME）：6个月的旋转试验结果
2. Intravitreal Aflibercept Injection (IAI) for Persistent Diabetic Macular Edema (DME) after Treatment with Bevacizumab and/or Ranibizumab: 6-Month ROTATED Trial Results [J] . Marcus Dennis M., Frazier Heather, Rex Priscila, Investigative ophthalmology & visual science . 2018,第9期

机译：用Bevacizumab和/或Ranibizumab治疗后玻术患者玻璃体糖尿病（IAI）用于持续糖尿病黄斑水肿（DME）：6个月的旋转试验结果
3. Intravitreal Aflibercept Injection (IAI) for Persistent Diabetic Macular Edema (DME) after Treatment with Bevacizumab and/or Ranibizumab: ROTATED Trial 52 Week Results [J] . Taylor Caitlen, Frazier Heather, Rex Priscila, Investigative ophthalmology & visual science . 2019,第9期

机译：用Bevacizumab和/或Ranibizumab治疗后，玻术术治疗后的玻术AfliBercept（IAI）用于持续糖尿病性黄斑（DME）：旋转试验52周结果
4. Morphology of vascular network in eyes with diabetic macular edema varies based on tolerance of aflibercept treatment interval length: preliminary findings [C] . Prateek Prasanna, Justis Ehlers, Nathaniel Braman, Biomedical Applications in Molecular, Structural, and Functional Imaging . 2019

机译：患有糖尿病黄斑水肿的眼睛中血管网络的形态基于AfliBercept治疗间隔长度的耐受性因耐受性而变化：初步调查结果
5. Prediction of visual acuity loss and indications for laser treatment in patients with diabetic macular edema using the Heidelberg Retina Tomograph. [D] . O'Neal, Dennis A. 2007

机译：使用海德堡视网膜断层扫描仪预测糖尿病性黄斑水肿患者的视力下降和激光治疗的适应症。
6. Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: a review of VIVID-DME and VISTA-DME data [O] . Focke Ziemssen, Patricio G. Schlottman, Jennifer I. Lim, 2016

机译：糖尿病性黄斑水肿患者玻璃体腔注射阿柏西普治疗的启动：VIVID-DME和VISTA-DME数据综述
7. Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: a review of VIVID-DME and VISTA-DME data [O] . Focke Ziemssen, Patricio G. Schlottman, Jennifer I. Lim, 2016

机译：糖尿病性黄斑水肿患者玻璃体腔注射阿柏西普治疗的启动：VIVID-DME和VISTA-DME数据综述

Intravitreal Aflibercept Injection (IAI) for Persistent Diabetic Macular Edema (DME) after Treatment with Bevacizumab and/or Ranibizumab: 6-Month ROTATED Trial Results

著录项

相似文献

相关主题

期刊订阅